Italy bans Novartis vaccines even after company assures their safety

Johnson & Johnson withholds its flu vaccine for tests on quality By Eric Palmer Italy is having a difficult time getting flu vaccine. Italian authorities today said they are banning ...

Agenus commences Phase 2 study of HerpV vaccine for treatment of genital herpes

Agenus (AGEN) announced that it has initiated a Phase 2 randomized, double-blind, multicenter study of HerpV, a recombinant “off-the-shelf” therapeutic vaccine candidate ...

Sleep Tight: Vaccine Not Linked To Narcolepsy

By Ed Silverman One year after restricting usage of the Pandremix vaccine over concerns there was a link to narcolepsy, the European Medicines Agency has decided there is insufficient ...

Novavax rises on results for bird flu vaccine

Novavax shares rocket on preliminary results for experimental bird flu vaccine ROCKVILLE, Md. (AP) — Shares of Novavax Inc. surged in premarket trading, after the company said ...

Nabi says nicotine vaccine fails again

Nabi: Combination of anti-smoking vaccine and Chantix didn’t work better than Chantix alone By Associated Press ROCKVILLE, Md. (AP) — Nabi Biopharmaceuticals Inc. said ...

HPV Vaccines, Promiscuous Sex & Young Girls

By Ed Silverman Ever since Gardasil was approved six years ago to combat various strains of the human papillomavirus, or HPV, which can lead to cervical cancer, some parents and social ...

A Drug to Quicken the Blood

By KATHLEEN SHARP Santa Barbara, Calif. AN anemia drug has likely harmed hundreds of thousands of patients, soiled the reputations of two Fortune 500 companies and shamed one of our ...

Izvestia: Abbott engineers Russian vaccines buyout

By Tracy Staton Abbott Laboratories may be close to a Russian buyout. According to government sources, the U.S.-based company wants to acquire its flu-vaccines partner, Petrovax. If ...

The Provenge Vaccine & A Discrepancy Over Data

By Ed Silverman Earlier this year, a former hedge fund manager named Marie Huber co-authored a medical study that questioned the benefit of the Provenge prostate cancer vaccine, prompting ...

Inovio touts DNA vaccine breakthrough in tiny PoC study

By John Carroll In a small study, an experimental therapeutic cervical cancer vaccine developed by Inovio Pharmaceuticals ($INO) appeared to spur a surge in T cells, leading the investigators ...

Gates Foundation jumps into $30M round for Genocea’s T cell vaccines

By John Carroll The 2008 Fierce 15 biotech Genocea Biosciences has picked up a key endorsement and a sizeable amount of cash today as the Bill & Melinda Gates Foundation joined ...

Merck taps startup from Down Under for vaccine patch

By Ryan McBride Merck ($MRK), one of the largest vaccine makers in the word, has formed an alliance with Vaxxas to research the startup’s drug-delivery patch for one of the ...
Page 2 of 3123
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS